BP today defends its practices in the civil trial against the parties involved with the 2010 Gulf oil spill. It must show it is safer, without ever having behaved dangerously.
FORTUNE -- Three years after BP's Gulf oil spill, the company must legally prove that it messed up, but it didn't mess up that bad.
BP (BP) launched its defense on Monday during the seventh week of a civil trial to determine MOREShelley DuBois, writer-reporter - Apr 8, 2013 1:05 PM ET
Food companies are launching campaigns for products they call crazy. Instead of grossing out consumers, it's creating a nation of 'loco-vores.'
FORTUNE -- At a certain point, we mature past eating food on a dare. If someone describes something by using the phrase, "That's crazy," you generally wouldn't put it in your mouth. But some food companies are making money hand over fist on products that they freely admit you MOREShelley DuBois, writer-reporter - Apr 8, 2013 5:00 AM ET
ESPN announced it would extend its partnership with the WNBA until 2022. Are we ready for the next step in women's sports?Shelley DuBois, writer-reporter - Mar 29, 2013 9:50 AM ET
Evangelical pastor Rob Bell discusses how to be a relevant leader and the business quirks of the "church world."Shelley DuBois, writer-reporter - Mar 28, 2013 1:17 PM ET
Keeping supply below demand has fueled Lululemon's impressive growth. How will it manage a demand shortage that's out of its control?Shelley DuBois, writer-reporter - Mar 22, 2013 2:16 PM ET
The world has since changed, but cultural norms stick around long after they're relevant. In many ways, America has a business culture that stems from the Gilded Age.Shelley DuBois, writer-reporter - Mar 22, 2013 5:00 AM ET
Airbus beat out Boeing for a $24 billion contract to supply long-time Boeing customer Lion Air. What does that mean for the American aircraft maker's competitive advantage?Shelley DuBois, writer-reporter - Mar 19, 2013 2:35 PM ET
Crave founder Ti Chang speaks with Fortune about how to bring quality design to a stigmatized industry.Shelley DuBois, writer-reporter - Mar 13, 2013 1:24 PM ET
China needs copper in ways that more mature markets don't. So they are taking their time reviewing the commodities megamerger.Shelley DuBois, writer-reporter - Mar 6, 2013 12:49 PM ET
Big Pharma companies have hit a wall chasing billion-dollar drugs. Novartis CEO Joseph Jimenez outlines a new paradigm for blockbuster medications.
FORTUNE -- Big Pharma is still big, but its business model is dying. For years, the game in pharmaceuticals has been to research, discover and then fiercely defend billion-dollar drugs.
But several mighty drug companies are losing the rights to exclusively own the formulas for best-selling drugs. Take Pfizer (PFE), which MOREShelley DuBois, writer-reporter - Mar 4, 2013 5:00 AM ET
|Don't fight it. Bitcoin has a bright future|
|"The Hobbit" dispute sparks lawsuit|
|China's bad debt breaks Hong Kong IPO logjam|
|I work 4 jobs and I'm still struggling|
|Premarkets: Stocks' disappointing December continues|